Skip to main content
. 2022 Sep 13;12:914385. doi: 10.3389/fonc.2022.914385

Figure 1.

Figure 1

Flowchart shows the patients’ selection process. BCLC, Barcelona Clinic Liver Cancer; HCC, hepatocellular carcinoma; TACE, transarterial chemoembolization; ICIs, immune checkpoint inhibitors; T+S, transarterial chemoembolization+sorafenib; T+S+ICIs, transarterial chemoembolization+sorafenib+immune checkpoint inhibitors.